EPISURF MEDICAL AB (PUBL) PUBLISHES PROSPECTUS
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN, HONG KONG, SWITZERLAND, SINGAPORE OR NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL. Episurf Medical AB (publ) ("Episurf") today publishes a prospectus since the shares of series B in Episurf which were issued by way of a resolution of the general meeting held on 7 December 2018 in accordance with previous announcements shall be admitted to trading on the regulated market Nasdaq